Radiology, Vol 182, 675-683, Copyright © 1992 by Radiological Society of North America

ARTICLES

Reperfusion and irreversible myocardial injury: identification with a nonionic MR imaging contrast medium

M Saeed, MF Wendland, Y Takehara, T Masui and CB Higgins
Department of Radiology, University of California, San Francisco 94143.

The potential of a new nonionic gadolinium complex--gadodiamide injection--to (a) allow distinction between reperfused and occlusive infarction and (b) enable differentiation between reperfused reversible and irreversible myocardial injury was investigated. Three groups of rats were used: 10 with reversibly reperfused myocardial injury, 10 with irreversibly reperfused injury, and 10 with occlusive infarction. Before administration of contrast material, there was no significant difference in signal intensity between normal and injured regions on T1- weighted images. After administration of gadodiamide injection (0.2 mmol/kg), the reversibly injured myocardium was indistinguishable from normal myocardium, while the reperfused irreversibly injured zone showed prominent and homogeneous enhancement. Occlusive infarcts showed three zones of differential enhancement consisting of normal, periinfarction, and infarction regions. Gadodiamide injection provides differential enhancement in reversibly reperfused, irreversibly reperfused, and occlusive infarcts. Thus, it may be useful as a marker of reperfusion and extent of infarction after thrombolytic therapy.

This article has been cited by other articles:

				C. R. Weiss, A. H. Aletras, J. F. London, J. L. Taylor, F. H. Epstein, R. Wassmuth, R. S. Balaban, and A. E. Arai Stunned, Infarcted, and Normal Myocardium in Dogs: Simultaneous Differentiation by Using Gadolinium-enhanced Cine MR Imaging with Magnetization Transfer Contrast Radiology, March 1, 2003; 226(3): 723 - 730. [Abstract] [Full Text] [PDF]

				S. I. Choi, S. H. Choi, S. T. Kim, K. H. Lim, C. H. Lim, G. Y. Gong, H. Y. Kim, H.-J. Weinmann, and T.-H. Lim Irreversibly Damaged Myocardium at MR Imaging with a Necrotic Tissue-Specific Contrast Agent in a Cat Model Radiology, June 1, 2000; 215(3): 863 - 868. [Abstract] [Full Text]

				R. J. Kim, D. S. Fieno, T. B. Parrish, K. Harris, E.-L. Chen, O. Simonetti, J. Bundy, J. P. Finn, F. J. Klocke, and R. M. Judd Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile Function Circulation, November 9, 1999; 100(19): 1992 - 2002. [Abstract] [Full Text] [PDF]

				M. Saeed, J. Bremerich, M. F. Wendland, R. Wyttenbach, H.-J. Weinmann, and C. B. Higgins Reperfused Myocardial Infarction as Seen with Use of Necrosis-specific versus Standard Extracellular MR Contrast Media in Rats Radiology, October 1, 1999; 213(1): 247 - 257. [Abstract] [Full Text]

				W. J. Rogers Jr, C. M. Kramer, G. Geskin, Y.-L. Hu, T. M. Theobald, D. A. Vido, S. Petruolo, and N. Reichek Early Contrast-Enhanced MRI Predicts Late Functional Recovery After Reperfused Myocardial Infarction Circulation, February 16, 1999; 99(6): 744 - 750. [Abstract] [Full Text] [PDF]

				M. G. Friedrich, O. Strohm, J. Schulz-Menger, H. Marciniak, F. C. Luft, and R. Dietz Contrast Media–Enhanced Magnetic Resonance Imaging Visualizes Myocardial Changes in the Course of Viral Myocarditis Circulation, May 19, 1998; 97(18): 1802 - 1809. [Abstract] [Full Text] [PDF]

				R. M. Judd, C. H. Lugo-Olivieri, M. Arai, T. Kondo, P. Croisille, J. A.C. Lima, V. Mohan, L. C. Becker, and E. A. Zerhouni Physiological Basis of Myocardial Contrast Enhancement in Fast Magnetic Resonance Images of 2-Day-Old Reperfused Canine Infarcts Circulation, October 1, 1995; 92(7): 1902 - 1910. [Abstract] [Full Text]